NasdaqGM - Nasdaq Real Time Price USD
ADMA Biologics, Inc. (ADMA)
20.48
-0.39
(-1.87%)
As of 12:09:00 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
101,215
118,672
8,800
-59,508
-112,369
Investing Cash Flow
-10,933
-8,575
-4,981
-13,911
-13,511
Financing Cash Flow
-63,982
-58,302
-38,989
108,852
121,048
End Cash Position
71,625
103,147
51,352
86,522
51,089
Income Tax Paid Supplemental Data
--
9,392
0
0
--
Interest Paid Supplemental Data
--
10,668
18,051
13,880
11,159
Capital Expenditure
-10,933
-8,575
-4,981
-13,911
-13,511
Issuance of Capital Stock
--
0
0
64,645
121,144
Issuance of Debt
--
0
135,000
151,750
0
Repayment of Debt
--
-60,000
-158,601
-100,036
-34
Free Cash Flow
90,282
110,097
3,819
-73,419
-125,880
12/31/2021 - 10/17/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CPRX Catalyst Pharmaceuticals, Inc.
26.20
+1.39%
EXEL Exelixis, Inc.
42.90
-0.05%
TGTX TG Therapeutics, Inc.
39.69
-0.38%
RYTM Rhythm Pharmaceuticals, Inc.
66.13
-0.88%
CORT Corcept Therapeutics Incorporated
73.14
+3.63%
XERS Xeris Biopharma Holdings, Inc.
4.5200
+0.89%
HALO Halozyme Therapeutics, Inc.
54.21
-0.31%
VRNA Verona Pharma plc
86.51
+2.21%
NAGE Niagen Bioscience, Inc.
13.23
-1.49%
ARGX argenx SE
581.12
-0.43%